| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |